Latest Videos - Onco'Zine 2017-03-27T02:50:02Z http://oncozine.com/video/video/rss?xn_auth=no ASCO 2014 Annual Meeting: Science and Society tag:oncozine.com,2014-05-29:2830291:Video:28450 2014-05-29T03:12:04.768Z Editorial Team http://oncozine.com/profile/EditorialTeam 2013-2014 ASCO President Clifford A. Hudis, MD, Chief, Breast Cancer Medicine Service explains his choice of "Science and Society" as the theme for the 2014 ASCO Annual Meeting and his presidential year. 2013-2014 ASCO President Clifford A. Hudis, MD, Chief, Breast Cancer Medicine Service explains his choice of "Science and Society" as the theme for the 2014 ASCO Annual Meeting and his presidential year. Over-regulation of Opioid Analgesics Catastrophic tag:oncozine.com,2013-12-01:2830291:Video:27097 2013-12-01T06:00:50.109Z Editorial Team http://oncozine.com/profile/EditorialTeam Andreas Ullrich, MD, MPH,<br></br> World Health Organization's Medical Officer for Cancer highlights that the ESMO-led GOPI survey brings the right data at the right moment for the WHO action plan on non-communicable diseases, to catalyze the passage from pilot project to national policy in each country.<p></p> <p><strong>For more information:</strong><br></br><a href="http://oncozine.com/profiles/blogs/regulation-opioid-analgesics-catastrophically-difficult-to-access" target="_blank">Over-regulation…</a></p> Andreas Ullrich, MD, MPH,<br /> World Health Organization's Medical Officer for Cancer highlights that the ESMO-led GOPI survey brings the right data at the right moment for the WHO action plan on non-communicable diseases, to catalyze the passage from pilot project to national policy in each country.<p></p> <p><strong>For more information:</strong><br/><a href="http://oncozine.com/profiles/blogs/regulation-opioid-analgesics-catastrophically-difficult-to-access" target="_blank">Over-regulation of Opioid Analgesics Makes it Catastrophically Difficult to Provide Basic Medication to Relieve Strong Cancer Pain</a></p> Transcription factor ATF3 links host adaptive response to breast cancer metastasis tag:oncozine.com,2013-08-23:2830291:Video:25916 2013-08-23T06:12:25.916Z Editorial Team http://oncozine.com/profile/EditorialTeam Early stages of cancer are characterized by an active host immune response that inhibits cancer progression; overtime, however, these responses are co-opted by the cancer cells to promote tumor growth. Tsonwin Hai and colleagues identified the transcription factor ATF3 as a key regulator of the host immune response and as a contributor to co-option of the host by cancer cells to promote metastasis.<br></br> • ATF3 is expressed in immune mononuclear cells in human breast tumors and is associated… Early stages of cancer are characterized by an active host immune response that inhibits cancer progression; overtime, however, these responses are co-opted by the cancer cells to promote tumor growth. Tsonwin Hai and colleagues identified the transcription factor ATF3 as a key regulator of the host immune response and as a contributor to co-option of the host by cancer cells to promote metastasis.<br /> • ATF3 is expressed in immune mononuclear cells in human breast tumors and is associated with worse clinical outcomes.<br /> • Host ATF3 expression facilitates breast cancer metastasis.<br /> • ATF3 alters the host systemic environment, increasing the number of tumor-associated macrophages.<br /> • Cancer-induced ATF3 expression in mononuclear cells alters gene expression and bioactivity to contribute to host-enhanced metastasis.<br /> <br /> Read the <a target="_blank">full article</a> ASCO 2013 - Edith Mitchell, MD, FACP, Cancer Disparities tag:oncozine.com,2013-07-01:2830291:Video:25294 2013-07-01T20:57:35.649Z Editorial Team http://oncozine.com/profile/EditorialTeam <a href="http://oncozine.com/video/asco-2013-edith-mitchell-md-facp-cancer-disparities"><br /> <img alt="Thumbnail" height="180" src="http://api.ning.com:80/files/uitupUukk-*mNaWI1DpnazTK*sT9rY0tPicZUGCgUatnpOD90vcE8lrkmn1RETDDTrc6FtyIlqFUgxJY8B2WVYMmM7UrjWLi/1028465766.jpeg?width=240&amp;height=180" width="240"></img><br /> </a> <br></br>At the ASCO 2013 Meeting, Edith Mitchell, MD, FACP, from the Kimmel Cancer Center at Thomas Jefferson University discusses the need for elimination of cancer disparities in the treatment of patients.<br></br> <br></br> For more information, please go to: <a target="_blank"><br></br> Center To Eliminate Cancer…</a> <a href="http://oncozine.com/video/asco-2013-edith-mitchell-md-facp-cancer-disparities"><br /> <img src="http://api.ning.com:80/files/uitupUukk-*mNaWI1DpnazTK*sT9rY0tPicZUGCgUatnpOD90vcE8lrkmn1RETDDTrc6FtyIlqFUgxJY8B2WVYMmM7UrjWLi/1028465766.jpeg?width=240&amp;height=180" width="240" height="180" alt="Thumbnail" /><br /> </a><br />At the ASCO 2013 Meeting, Edith Mitchell, MD, FACP, from the Kimmel Cancer Center at Thomas Jefferson University discusses the need for elimination of cancer disparities in the treatment of patients.<br /> <br /> For more information, please go to: <a target="_blank"><br /> Center To Eliminate Cancer Disparities</a> ASCO 2013 - Dr. G. S. Bhattacharyya on Metronomic dosing in triple negative breast cancer tag:oncozine.com,2013-07-01:2830291:Video:25217 2013-07-01T20:51:26.813Z Editorial Team http://oncozine.com/profile/EditorialTeam <a href="http://oncozine.com/video/asco-2013-dr-g-s-bhattacharyya-on-metronomic-dosing-in-triple"><br /> <img alt="Thumbnail" height="180" src="http://api.ning.com:80/files/uitupUukk-8YisIqrYYnjDNYfWdBbtckLW7Vek7C-HSLAWkEtCkUhtw*qUecvy3ir7bbA7b8vQOoPMPFJTyJe0ZlcyEaKgIU/1028465148.jpeg?width=240&amp;height=180" width="240"></img><br /> </a> <br></br>At the ASCO 2013 Meeting, Dr. G. S. Bhattacharyya of the Metronomics Global Health Initiative and in-charge of the Department of Medical Oncology of the Fortis Hospital, in Anandapur, Kolkataand of the Department of Medical Oncology in the AMRI Hospital,of Dhakuria, Kolkata discusses Metronomic dosing in triple negative breast cancer.<br></br> <br></br> For more… <a href="http://oncozine.com/video/asco-2013-dr-g-s-bhattacharyya-on-metronomic-dosing-in-triple"><br /> <img src="http://api.ning.com:80/files/uitupUukk-8YisIqrYYnjDNYfWdBbtckLW7Vek7C-HSLAWkEtCkUhtw*qUecvy3ir7bbA7b8vQOoPMPFJTyJe0ZlcyEaKgIU/1028465148.jpeg?width=240&amp;height=180" width="240" height="180" alt="Thumbnail" /><br /> </a><br />At the ASCO 2013 Meeting, Dr. G. S. Bhattacharyya of the Metronomics Global Health Initiative and in-charge of the Department of Medical Oncology of the Fortis Hospital, in Anandapur, Kolkataand of the Department of Medical Oncology in the AMRI Hospital,of Dhakuria, Kolkata discusses Metronomic dosing in triple negative breast cancer.<br /> <br /> For more information, please go to <a target="_blank">The Metronomics Global Health Health Initiative</a>